Menu
Back to User profile » Dr Chih-Cheng Lai
Papers published by Dr Chih-Cheng Lai:
Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
Tsai CH, Chen YC, Chen PY, Lai CC, Tang HJ, Chuang YC, Chen CC, Ho CH, Hsu WY, Chang TH
Infection and Drug Resistance 2023, 16:5599-5611
Published Date: 25 August 2023
The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year
Cheng KC, Lai CC, Wang CY, Wang CM, Ho CH, Sung MI, Hsing SC, Liao KM, Ko SC
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:883-891
Published Date: 21 April 2022
Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
Chen CH, Tu CY, Chen WC, Kuo LK, Wang YT, Fu PK, Ku SC, Fang WF, Chen CM, Lai CC
Infection and Drug Resistance 2021, 14:2251-2258
Published Date: 16 June 2021
The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:155-156
Published Date: 21 January 2020
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
Wang CY, Hu YL, Wang YH, Chen CH, Lai CC, Huang KL
Infection and Drug Resistance 2019, 12:2251-2257
Published Date: 22 July 2019
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1539-1548
Published Date: 11 July 2019
Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials
Lan SH, Lai CC, Lu LC, Chang SP, Huang HT
Infection and Drug Resistance 2019, 12:1415-1423
Published Date: 27 May 2019
Comparison of high-dose, short-course levofloxacin treatment vs conventional regimen against acute bacterial infection: meta-analysis of randomized controlled trials
Chen CW, Chen YH, Cheng IL, Lai CC
Infection and Drug Resistance 2019, 12:1353-1361
Published Date: 17 May 2019
The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials
Chen CW, Chang SP, Huang HT, Tang HJ, Lai CC
Infection and Drug Resistance 2019, 12:1303-1310
Published Date: 15 May 2019
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Lai CC, Chen YS, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR
Infection and Drug Resistance 2019, 12:627-640
Published Date: 14 March 2019
The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
Chang SP, Lee HZ, Lai CC, Tang HJ
Infection and Drug Resistance 2019, 12:433-438
Published Date: 14 February 2019
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2019, 12:25-29
Published Date: 20 December 2018
Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan
Lai CC, Chen CC, Lu YC, Chen HJ, Su BA, Weng TC, Chiu YH, Toh HS, Zhang CC, Chiang SR, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:2555-2560
Published Date: 7 December 2018
The association between COPD and outcomes of patients with advanced chronic kidney disease
Lai CC, Wu CH, Wang YH, Wang CY, Wu VC, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2899-2905
Published Date: 17 September 2018
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
Lai CC, Chen CC, Lu YC, Lin TP, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:1441-1445
Published Date: 11 September 2018
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:681-687
Published Date: 3 May 2018
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:867-874
Published Date: 8 March 2018
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996
Published Date: 11 October 2017
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2477-2485
Published Date: 21 August 2017
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2775-2783
Published Date: 8 November 2016